Skip to main
BCPC
BCPC logo

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is forecasted to see a steady increase in GAAP earnings, projecting $4.73 per diluted share for 2025 and $5.17 for 2026, indicating strong anticipated growth driven by the Human Nutrition and Health segment. The company's 2Q25 results showcased top-line revenue of $255.5 million, surpassing estimates and showing year-over-year growth, along with continuous improvements in gross and net margins expected in the near future. Additionally, Balchem is projected to achieve a debt-free status by the end of the coming year, which may enable the company to consider strategic mergers and acquisitions, thereby enhancing its financial stability and growth potential.

Bears say

Balchem Corp's financial outlook appears negative due to a decline in its P/E multiple from 39.6x to 37.9x, which reflects a deteriorating market sentiment compared to the prior period. The company faces several risks, including slower-than-anticipated growth in its baseline businesses, inflationary pressures, and challenges surrounding the launch of new nutrition products, which collectively could hamper future performance. Additionally, recent sales in key segments, such as the animal health and nutrition segment, missed estimates with reported sales of $56.4M against an expected $60M, indicating potential operational weaknesses.

Balchem (BCPC) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Balchem (BCPC) has a Strong Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $190, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $190, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.